Back

Stepwise intensification of guideline-directed medical therapy is associated with reduced major adverse kidney events in patients with HFpEF and diabetes

28 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: When heart, kidney, and metabolism collide: risk and missed opportunities in care Renal Failure and Cardiovascular Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Yu Hoshika

Nippon Medical School Teaching Hospital, Tokyo (Japan)

7 More presentations in this session

Presentation thumbnail
Association of remnant cholesterol levels with the initiation of kidney replacement therapy in patients with chronic kidney disease: results from the KNOW-CKD study
Professor K. Oh (Seoul, KR)
Presentation thumbnail
Persistent gender differences in the management of chronic kidney disease in patients with heart failure – follow-up of the InspeCKD study
Professor F. Mader (Erfurt, DE)
Abstract Slides Video
Presentation thumbnail
Association of cardiovascular-kidney-metabolic syndrome with cardiovascular mortality: a prospective cohort study in Madeira Island
Doctor F. Sousa (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of chronic kidney disease and renal safety of contemporary therapies in patients with heart failure: a real-world analysis
Doctor P. Trapanese (Modena, IT)
Abstract Slides Video
Presentation thumbnail
Bidirectional mendelian randomisation of kidney function and heart failure in african-ancestry populations
Doctor N. GAYE (Dakar, SN)
Abstract Slides Video

Access the full session

Session thumbnail
When heart, kidney, and metabolism collide: risk and missed opportunities in care

The Event

Event poster

ESC Congress 2026

28 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Guideline-directed medical therapy use in patients with incident comorbid heart failure and chronic kidney disease (The CaRe Study)
1 September 2025
thumbnail
Congress Session
Is left ventricular ejection fraction still relevant for guideline-directed medical therapy implementation?
18 May 2025
thumbnail
Congress Presentation
Association of kidney and cardiovascular outcomes in patients with type 2 diabetes mellitus: insights from the EMPA-REG OUTCOME trial
29 June 2021
thumbnail
Congress Presentation
Four pillars of HFrEF: pilot study with real-world data
20 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources